LUV Systems Completes Independent Testing for halō Indoor Air Disinfection System
GARDENA, CA (December 18, 2020) - LUV Systems, Inc. today announced the completion of final spectroscopy and airflow aerodynamic testing for its halō Model 5R/M air disinfection system, marking a significant milestone in the validation and commercialization of its low-wavelength ultraviolet (UVC) technology platform.
The halō Model 5R/M is the first in LUV Systems’ portfolio of low-UVC disinfection products designed for use in occupied indoor environments. Independent testing was conducted by third-party firms, including The Earthineering Company and JMTECH, to validate system performance and confirm key design parameters. The patent-pending system integrates a fan and LUV™ light ring to capture air from the breathing zone, disinfect it using a controlled UVC dose, and recirculate cleaned air into the indoor environment.
Dr. Kevin Hickerson, Principal at The Earthineering Company, commented on the results: “The halō Model 5R/M performed as designed, delivering the required UVC dose to achieve targeted viral inactivation levels, including for SARS-CoV-2.”
Chief Executive Officer Anu Sood emphasized the importance of this milestone: “With independent validation of our core system parameters—including airflow dynamics, spectral dose, and residence time—we have established a strong technical foundation. We are now integrating these results with ongoing third-party COVID-19 research at Boston University as we advance toward final product launch.”
The company has defined four critical design parameters that guide system performance: effective coverage within the breathing zone, equivalent air changes per hour for a 10,000 cubic-foot indoor space, spectral dose delivery, and air residence time required for effective disinfection.
Danish Khatri, Principal Engineer at LUV Systems, added: “Independent testing has confirmed our theoretical models and engineering assumptions. These results significantly de-risk product performance as we move toward commercialization.”
Neeraj Chaudhary, Business Analyst at LUV Systems, highlighted the broader market opportunity: “Our solutions are designed to meet growing demand for affordable, effective air disinfection across healthcare, residential, commercial, education, retail, entertainment, and transportation sectors.”
LUV Systems continues to make progress across key milestones, including patent filings, laboratory validation on real-world surfaces, UVC inactivation of SARS-CoV-2, dose modeling, prototype testing, and manufacturing sourcing. The company has also developed a proprietary dosing algorithm that correlates surface viral inactivation data with effective indoor air disinfection rates, supporting predictable and scalable performance across diverse applications.
LUV Systems’ product strategy is centered on three core value drivers:
- Proven Effectiveness against a broad range of airborne and surface pathogens;
- Engineered Safety for use in occupied environments, including around people and pets; and
- Affordability to enable widespread adoption across consumer and commercial markets.
Ultraviolet disinfection has been used for more than a century in applications such as healthcare, laboratories, and water treatment, underscoring its established efficacy and long-term market relevance.
With independent validation completed, LUV Systems is advancing final design optimization and positioning its low-UVC technology platform for commercialization across large and diversified global markets.
Leave a comment